BDBM350531 N-(4-bromophenyl)-2-(4-cyclopropyl- 4-methyl-2,5-dioxoimidazolidin-1- yl)acetamide::US10208071, Table 3.7::US10799518, Structure TABLE 3.7

SMILES CC1(NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O)C1CC1

InChI Key InChIKey=VFHJIKCFNPPHJA-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350531   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350531(N-(4-bromophenyl)-2-(4-cyclopropyl- 4-methyl-2,5-d...)
Affinity DataEC50:  166nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350531(N-(4-bromophenyl)-2-(4-cyclopropyl- 4-methyl-2,5-d...)
Affinity DataEC50:  1.66E+5nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent